- Home
- WINT vs SBET Comparison
WINT vs SBET Comparison
Compare WINT & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- SBET
- Stock Information
- Founded
- WINT 1992
- SBET 1995
- Country
- WINT United States
- SBET United States
- Employees
- WINT N/A
- SBET N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- SBET Computer Software: Prepackaged Software
- Sector
- WINT Health Care
- SBET Technology
- Exchange
- WINT Nasdaq
- SBET Nasdaq
- Market Cap
- WINT 2.0M
- SBET 1.6M
- IPO Year
- WINT 1995
- SBET 1997
- Fundamental
- Price
- WINT $0.12
- SBET $0.44
- Analyst Decision
- WINT Hold
- SBET
- Analyst Count
- WINT 1
- SBET 0
- Target Price
- WINT $7.00
- SBET N/A
- AVG Volume (30 Days)
- WINT 7.3M
- SBET 554.8K
- Earning Date
- WINT 11-27-2024
- SBET 11-15-2024
- Dividend Yield
- WINT N/A
- SBET N/A
- EPS Growth
- WINT N/A
- SBET N/A
- EPS
- WINT N/A
- SBET 1.81
- Revenue
- WINT N/A
- SBET $3,866,015.00
- Revenue This Year
- WINT N/A
- SBET N/A
- Revenue Next Year
- WINT N/A
- SBET N/A
- P/E Ratio
- WINT N/A
- SBET $0.26
- Revenue Growth
- WINT N/A
- SBET 56.18
- 52 Week Low
- WINT $0.11
- SBET $0.33
- 52 Week High
- WINT $14.75
- SBET $1.68
- Technical
- Relative Strength Index (RSI)
- WINT 15.60
- SBET 39.35
- Support Level
- WINT $0.21
- SBET $0.33
- Resistance Level
- WINT $0.33
- SBET $0.59
- Average True Range (ATR)
- WINT 0.03
- SBET 0.07
- MACD
- WINT 0.00
- SBET 0.00
- Stochastic Oscillator
- WINT 2.15
- SBET 41.92
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the Company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The Company has two operating segments: Affiliate Marketing Services-United States and Affiliate Marketing Services-International. The company generates the majority of the revenue earned from the Affiliate Marketing Services-International segment.